Cardiovascular Research - Immunity and Atherosclerosis
121 – 130 of 559
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated IL-27 in patients with acute coronary syndrome is associated with adverse ventricular remodeling and increased risk of recurrent myocardial infarction and cardiovascular death
(
- Contribution to journal › Article
-
Mark
Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals
(
- Contribution to journal › Article
-
Mark
A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis
(
- Contribution to journal › Article
-
Mark
Increased vascular endothelial growth factor D is associated with atrial fibrillation and ischaemic stroke
(
- Contribution to journal › Article
-
Mark
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes : A nested, case–control study
(
- Contribution to journal › Article
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Circulating HER2/ErbB2 Levels Are Associated With Increased Incidence of Diabetes : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Sarcopenia is common in adults with complex congenital heart disease
(
- Contribution to journal › Article
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
(
- Contribution to journal › Article